The hypothesis is that genes involved in epigenetic modifications, such as SIRT1, SIRT3, SIRT6, FOXO1, FOXO3A, DNMT3A, and ELAVL1, are critical for the development of sarcopenia and could be used as biomarkers for the diagnosis and monitoring of the disease. This evidence concerns the gene ELAVL1 and sarcopenia.